Atlas Trials

Vyriad, Inc.

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Vyriad, Inc.

RecordFirmDate
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients (NCT04291105)Vyriad, Inc.2020-04-24
Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors (NCT03647163)Vyriad, Inc.2019-04-09
Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy (NCT03171493)Vyriad, Inc.2018-07-20
Dose Escalation Trial of Intra-Tumoral Injection of NIS Measles Virus in Combination With Atezolizumab (NCT02919449)Vyriad, Inc.2017-08-03
Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors (NCT02923466)Vyriad, Inc.2017-04-17

Track Vyriad, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.